Tolerance induction by 'megadose' transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor

Current Opinion in Immunology

Volumn 12, Issue 5, 2000, Pages 536-541

  Reisner, Yair ^a   Martelli, Massimo F ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; CHILD; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; IMMUNE SYSTEM; LEUKEMIA; MAJOR CLINICAL STUDY; MORTALITY; NATURAL KILLER CELL; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 0033817081     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00135-7     Document Type: Review

References (47)

1. Marrow transplantation for malignant diseases
2. Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells
3. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency
4. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation
5. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow
6. HLA-haploidentical bone marrow transplantation for severe combined immune deficiency using E-rosette fractionation and cyclosporine
7. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells
8. Graft rejection and graft-versus-host disease: Mirror images
9. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes
10. The role of donor lymphoid cells in allogenelc marrow engraftment
11. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow
12. Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation
13. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors
14. Recipient Immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation
15. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
16. A correlation between conditioning and engraftment in recipients of MHC mismatched T cell-depleted murine bone marrow transplants
17. What can be done to prevent graft versus host disease?
18. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation
19. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
20. + Lin- cells and nonalloreactive T cells
21. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum
22. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
23. Transplantation of megadoses of purified haploidentical stem cells
24. Tolerance induction by 'megadose' hematopoietic transplants: Donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
25. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action
26. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC
27. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys
28. Specific in vitro inactivation of host anti-donor CTL-p by human CD34 progenitor cells: Evidence against anergy based mechanisms
29. The role of megadose CD34 in haploidentical transplantation: Potential application to tolerance induction
30. Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by sca- 1(+)Lin(-) bone marrow progenitor cells: Synergism with non-alloreactive (Host x Donor)F(1) T cells
31. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
32. G-CSF blocks IL-12 production by antigen presenting cells: Implications for improved immune reconstitution after haploidentical hematopoietic transplantation
33. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myeloablative conditioning
34. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
35. Cloned natural suppressor cells prevent lethal graft-vs-host disease
36. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity
37. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity
38. Veto-like down regulation of T helper cell reactivity in vivo by injection of semi-allogeneic spleen cells
39. + thymocytes
40. Clonal deletion of postthymic T cells: Veto cells kill precursor cytotoxic T lymphocytes
41. Do donor cells function as veto cells in the induction and maintenance of tolerance across an MHC disparity in mixed lymphoid radiation chimeras?
42. Thy 1+ donor cells function as veto cells in the maintenance of tolerance across a major histocompatibility complex disparity in mixed-lymphoid radiation chimeras
43. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
44. Enhancement of BM allografts by non-alloreactive donor CTL's: CD8 binding and Fas-FasL apoptosis mediate the veto effect
45. Inhibition of death receptor signals by cellular FLIP
46. Non-alloreactive donor anti-third party CTLs facilitate BM allografts across major histocompatibility barriers in sublethally irradiated mice